Naamit Sher

No más puestos en curso

71 años

Health Technology

Consumer Services

Perfil

Naamit Sher worked as the VP of Drug Development & Regulatory Affairs at Vascular Biogenics Ltd. She was also the Director of Quality Control & Quality Assurance at Interpharm Laboratories Ltd. and the Head of QC Laboratories at Teva Pharmaceutical Industries Ltd. Additionally, she held the title of Principal at Teva North America.
Dr. Sher received her undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.

Antiguos cargos conocidos de Naamit Sher.

Empresas	Cargo	Fin
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Corporate Officer/Principal	01/01/2006
Teva North America	Corporate Officer/Principal	-
Interpharm Laboratories Ltd. Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases	Corporate Officer/Principal	-
NOTABLE LABS, LTD.	Consejero General	-

Ver el detalle de la experiencia de Naamit Sher.

Formación de Naamit Sher.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Naamit Sher.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients	Health Technology
The Hebrew University of Jerusalem The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Teva North America
Interpharm Laboratories Ltd. Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases	Health Technology
Vascular Biogenics Ltd. Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer	Health Technology